NOVARTIS | 79.20 |
Date/Time | 06/28 / 17:25 |
Chg. / Chg.(%) | - / |
Bid | 77.92 / 35 |
Ask | 80.30 / 40 |
Open | 79.84 |
Previous Close | 79.44 |
High | 80.38 |
Low | 77.92 |
Volume [EUR] | 83,029.38 |
Volume [Units] | 1,042 |
Price fixings | 21 |
ISIN | CH0012005267 |
Security | NOVN |
Exchange | Borsa Italiana |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
London Inter.. | 79.13 | ![]() |
4,526,117 |
SIX Swiss Ex.. | 79.20 | ![]() |
2,221,184 |
Cboe Europe .. | 79.20 | ![]() |
180,333 |
Cboe Europe .. | 79.20 | ![]() |
138,785 |
Turquoise | 79.20 | ![]() |
69,062 |
Lang & Schwa.. | 71.580 | ![]() |
|
Nasdaq Other.. | 86.1131 | ![]() |
31,959 |
TradeGate | 80.000 | 16,350 | |
Frankfurt | 80.1600 | 1,589 | |
Borsa Italia.. | 79.20 | 1,042 | |
Hamburg | 80.19 | 1,000 | |
München | 80.10 | 55 | |
Berlin | 80.40 | 40 | |
gettex | 80.160 | 20 | |
Düsseldorf | 80.18 | 4 | |
Hannover | 80.10 | 0 | |
Borsa Italia.. | 75.00 | 36 | |
EUREX | Options |
News
- Chinook Therapeutics and Evotec Announce Strategic Collaboration to Discover and Develop Novel Precision Medicines for Chronic Kidney Diseases
14:15 - GlobeNewswire - Homology Medicines Regains Worldwide Rights to Ophthalmology Program Based on its In Vivo Nuclease-Free Gene Editing Platform
13:30 - GlobeNewswire - Novartis Entresto® granted expanded indication in chronic heart failure by FDA
02/16/2021 / 19:22 - GlobeNewswire - Novartis signs initial deal to manufacture Pfizer jabs
01/29/2021 / 13:04 - TeleTrader - Novartis Sees 6-Figure Savings with Qlik
01/26/2021 / 14:30 - GlobeNewswire